Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAH
- Rev/Share 984.4958
- Book/Share -11.4748
- PB -16.9824
- Debt/Equity -3.1372
- CurrentRatio 0.957
- ROIC 0.1177
- MktCap 48809682569.0
- FreeCF/Share 18.7059
- PFCF 10.9635
- PE 30.6535
- Debt/Assets 0.1635
- DivYield 0.0099
- ROE -0.55
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CAH | Wells Fargo | Equal Weight | Overweight | -- | $179 | June 3, 2025 |
| Upgrade | CAH | Jefferies | Hold | Buy | $140 | $150 | Feb. 5, 2025 |
| Upgrade | CAH | TD Cowen | Hold | Buy | $130 | $144 | Jan. 8, 2025 |
| Upgrade | CAH | Evercore ISI | In-line | Outperform | -- | $140 | Jan. 7, 2025 |
| Upgrade | CAH | BofA Securities | Neutral | Buy | $132 | $145 | Jan. 6, 2025 |
| Upgrade | CAH | Wells Fargo | Underweight | Equal Weight | $101 | $127 | Dec. 13, 2024 |
| Resumed | CAH | Mizuho | -- | Outperform | -- | $139 | Dec. 4, 2024 |
News
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. ( CAH ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good morning, everybody. Thanks for joining us.
Read More
4 Value Stocks With Strong Interest Coverage as Markets Rebound
Published: November 11, 2025 by: Zacks Investment Research
Sentiment: Positive
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
Read More
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice
Published: November 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?
Published: November 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Cardinal Health: Quiet Transformation, Clear Buy
Published: November 05, 2025 by: Seeking Alpha
Sentiment: Positive
Cardinal Health (CAH) is evolving into a specialty-focused healthcare leader, leveraging acquisitions and managed services for higher profitability and efficiency. CAH's financials show strong gross profit and net income growth, with operational leverage and robust free cash flow supporting ongoing investments and shareholder returns. Despite solid fundamentals, CAH trades at significant valuation discounts to peers.
Read More
Cardinal Health Rallies As Strong Start To 2026 Fuels Higher Earnings Guidance
Published: October 30, 2025 by: Benzinga
Sentiment: Positive
Cardinal Health Inc.'s (NYSE:CAH) stock surged on Thursday as the healthcare services company reported upbeat first-quarter 2026 earnings, with adjusted earnings of $2.55 per share, beating the consensus of $2.18.
Read More
Cardinal Health, Inc. (CAH) Q1 2026 Earnings Call Transcript
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. ( CAH ) Q1 2026 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief Financial Officer Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division George Hill - Deutsche Bank AG, Research Division Eric Percher - Nephron Research LLC Allen Lutz - BofA Securities, Research Division Kevin Caliendo - UBS Investment Bank, Research Division Eric Coldwell - Robert W. …
Read More
CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health delivered a strong Q1 beat and lifted its 2026 EPS outlook, fueled by broad-based growth and rising profits across all business segments.
Read More
Cardinal Health Surges After Reporting Strong Q1 Financial Results
Published: October 30, 2025 by: 24/7 Wall Street
Sentiment: Positive
Cardinal Health (NYSE: CAH) delivered a commanding first quarter for fiscal 2026, beating both earnings and revenue expectations by wide margins while raising full-year guidance.
Read More
Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Cardinal (CAH) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the closing of the recent trading day, Cardinal Health (CAH) stood at $161.89, denoting a +1.72% move from the preceding trading day.
Read More
Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Negative
CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.
Read More
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Neutral
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Published: October 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Read More
CAH Expands Distribution Network With Indianapolis Facility
Published: October 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
Read More
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cardinal Health to Build Indianapolis Pharma Plant to Supply Growing Distribution
Published: September 30, 2025 by: WSJ
Sentiment: Positive
The planned 230,000 square-foot plant is the healthcare company's latest step in a 10-year plan to modernize and expand its distribution network.
Read More
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
Published: September 30, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN, Ohio , Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network.
Read More
Cardinal (CAH) Upgraded to Buy: Here's What You Should Know
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Published: September 24, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (NYSE:CAH ) Bank of America Global Healthcare Conference 2025 September 24, 2025 11:10 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief Financial Officer Conference Call Participants Allen Lutz - BofA Securities, Research Division Presentation Allen Lutz BofA Securities, Research Division All right. Good morning, everyone.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason M. Hollar
- Employees 47922